Your Airplane Carry-on Bag Is About to Shrink
Are you one of those people who likes to brag about how you can fit a week’s worth of stuff into your carry-on suitcase? If so, your job is about to get harder.
The International Air Transport Association, a trade group representing some 250 airlines, has introduced a proposal to reduce the maximum allowable carry-on suitcase size. Under the proposed rule change, carry-on bags would have to be less than 21.5 x 13.5 x 7.5 inches. Current rules for carry-on size vary by airline, but they’re generally larger than that.
The organization claims that this would allow all passengers on a plane to store their bags in the cabin. “The development of an agreed optimal cabin bag size will bring common sense and order to the problem of differing sizes for carry-on bags,” IATA Senior Vice President for Airport, Passenger and Cargo Security said in a statement. “We know the current situation can be frustrating for passengers.
Related: 6 Sneaky Fees That Are Making Airlines a Bundle
Several major airlines have signaled interest in introducing the guidelines, according to IATA. Luggage manufacturers will start labeling bags that meet the new criteria as “IATA Cabin OK.”
The rule change may force more consumers to check luggage and pay the checked-bag fees many airlines have introduced in the past few years. Airlines typically charge $25 for the first bag, $35 for the second, and more than $100 for a third bag.
Some airlines, including Spirit, Allegiant and Frontier, also charge passengers for carry-on bags.
Chart of the Day: Boosting Corporate Tax Revenues
The leading candidates for the Democratic presidential nomination have all proposed increasing taxes on corporations, including raising income tax rates to levels ranging from 25% to 35%, up from the current 21% imposed by the Republican tax cuts in 2017. With Bernie Sanders leading the way at $3.9 trillion, here’s how much revenue the higher proposed corporate taxes, along with additional proposed surtaxes and reduced tax breaks, would generate over a decade, according to calculations by the right-leaning Tax Foundation, highlighted Wednesday by Bloomberg News.
Chart of the Day: Discretionary Spending Droops
The federal government’s total non-defense discretionary spending – which covers everything from education and national parks to veterans’ medical care and low-income housing assistance – equals 3.2% of GDP in 2020, near historic lows going back to 1962, according to an analysis this week from the Center on Budget and Policy Priorities.
Chart of the Week: Trump Adds $4.7 Trillion in Debt
The Committee for a Responsible Federal Budget estimated this week that President Trump has now signed legislation that will add a total of $4.7 trillion to the national debt between 2017 and 2029. Tax cuts and spending increases account for similar portions of the projected increase, though if the individual tax cuts in the 2017 Republican overhaul are extended beyond their current expiration date at the end of 2025, they would add another $1 trillion in debt through 2029.
Chart of the Day: The Long Decline in Interest Rates
Are interest rates destined to move higher, increasing the cost of private and public debt? While many experts believe that higher rates are all but inevitable, historian Paul Schmelzing argues that today’s low-interest environment is consistent with a long-term trend stretching back 600 years.
The chart “shows a clear historical downtrend, with rates falling about 1% every 60 years to near zero today,” says Bloomberg’s Aaron Brown. “Rates do tend to revert to a mean, but that mean seems to be declining.”
Chart of the Day: Drug Price Plans Compared
Lawmakers are considering three separate bills that are intended to reduce the cost of prescription drugs. Here’s an overview of the proposals, from a series of charts produced by the Kaiser Family Foundation this week. An interesting detail highlighted in another chart: 88% of voters – including 92% of Democrats and 85% of Republicans – want to give the government the power to negotiate prices with drug companies.
